| Combination of | |
|---|---|
| Prednisolone phosphate | Glucocorticoid |
| Fenoxazoline | Vasoconstrictor |
| Clinical data | |
| Other names | Prednisolone phosphate compound with fenoxazoline; LD-4003; 11β,17α,21-Trihydroxypregna-1,4-diene-3,20-dione 21-(dihydrogen phosphate) compound with 2-[(2-isopropylphenoxy)methyl]-2-imidazoline |
| Drug class | Corticosteroid; Glucocorticoid |
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
Prednazoline, a compound of prednisolone phosphate with fenoxazoline, is a synthetic corticosteroid as well as vasoconstrictor and α-adrenergic sympathomimetic.
| Glucocorticoids | |
|---|---|
| Antiglucocorticoids |
|
| Synthesis modifiers | |
| |
| Mineralocorticoids | |
|---|---|
| Antimineralocorticoids | |
| Synthesis modifiers | |
| |
| GRTooltip Glucocorticoid receptor |
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| MRTooltip Mineralocorticoid receptor |
| ||||
|---|---|---|---|---|---|